Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

Estimates of the worldwide incidence and mortality from 36 cancers and for all cancers combined for the year 2018 are now available in the GLOBOCAN 2018 database, compiled and disseminated by the International Agency for Research on Cancer (IARC). This paper reviews the sources and methods used in compiling the cancer statistics in 185 countries. The validity of the national estimates depends upon the representativeness of the source information, and to take into account possible sources of bias, uncertainty intervals are now provided for the estimated sex‐ and site‐specific all‐ages number of new cancer cases and cancer deaths. We briefly describe the key results globally and by world region. There were an estimated 18.1 million (95% UI: 17.5–18.7 million) new cases of cancer (17 million excluding non‐melanoma skin cancer) and 9.6 million (95% UI: 9.3–9.8 million) deaths from cancer (9.5 million excluding non‐melanoma skin cancer) worldwide in 2018.

[1]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[2]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[3]  F. Bray,et al.  A Global Cancer Surveillance Framework Within Noncommunicable Disease Surveillance: Making the Case for Population-Based Cancer Registries , 2017, Epidemiologic reviews.

[4]  M. Yokoo,et al.  Estimation of the global burden of mesothelioma deaths from incomplete national mortality data , 2017, Occupational and Environmental Medicine.

[5]  栗原 登,et al.  Trends cancer mortality for selected sites in 24 countries , 1960 .

[6]  T. Vos,et al.  Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement , 2016, PLoS medicine.

[7]  M. Plummer,et al.  Global burden of cancers attributable to infections in 2012: a synthetic analysis. , 2016, The Lancet. Global health.

[8]  G. Braemer.  International statistical classification of diseases and related health problems. Tenth revision. , 1988, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.

[9]  T. Hakulinen,et al.  Comparison of different approaches to incidence prediction based on simple interpolation techniques. , 2000, Statistics in medicine.

[10]  T. Vos,et al.  Global, regional, and national incidence and prevalence, and years lived with disability for 328 diseases and injuries in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017 .

[11]  J. Ferlay,et al.  An assessment of GLOBOCAN methods for deriving national estimates of cancer incidence , 2016, Bulletin of the World Health Organization.

[12]  Jacques Ferlay,et al.  Cancer incidence in five continents. , 1976, IARC scientific publications.

[13]  Carolyn Staines,et al.  Incidence and prevalence of non‐melanoma skin cancer in Australia: A systematic review , 2015, The Australasian journal of dermatology.

[14]  J. Ferlay,et al.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. , 2013, European journal of cancer.

[15]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[16]  Victor R. Preedy,et al.  United Nations Population Division , 2010 .

[17]  India,et al.  Cancer Incidence in Five Continents Vol. X , 2013 .

[18]  Joel E. Oestreich.  UNITED NATIONS DEVELOPMENT PROGRAMME , 2000 .